from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3449/mycP4

LFCtreatmentdescriptionclass of inhibitor

0.638

Amikacinug/mL Amikacintranslation

0.168

Cap5-10ug/mL Capreomycintranslation

0.132

Rox10-50 ug/mL Roxithromycintranslation

1.519

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.039

Rif0.2-5ug/mL Rifampicintranscription

0.685

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.004

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.572

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.627

CPZ10-50 ug/mL Chlorpromazinerespiration

0.378

Clofazimine10-13 ug/mL Clofaziminerespiration

1.009

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.197

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.090

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.698

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.308

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.580

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.471

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.510

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.530

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.156

Nigericin50 uM Nigericinrespiration

0.333

TRC10-150 ug/mL Triclosanrespiration

-0.005

TRZ10-25 ug/mL Thioridazinerespiration

0.234

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.831

menadione6-10 ug/mL Menadionerespiration

0.029

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.156

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.042

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.098

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.271

NRP_1Non-replicating persistence stage 1dosRassociated

-0.583

Amp0.2mg/mL AmpicillincellWall

0.025

Cephalexin20-100 ug/mL CephalexincellWall

-0.754

Cerulenin0.32-5 ug/mL CerulenincellWall

0.600

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.290

EMB10-20 ug/mL EthambutolcellWall

-0.158

Eta12-40 ug/mL EthionamidecellWall

0.874

INH0.2-0.4 ug/mL IsoniazidcellWall

0.462

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.041

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.378

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.204

BZA0.12 mg/mL BenzamidearomaticAmides

-0.083

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.293

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.528

H2O24 mM hydrogen peroxideDNAdamaging

-0.244

Levo10 ug/mL LevofloxacinDNAdamaging

0.323

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.249

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.247

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.270

UVUV-irradiationDNAdamaging

-1.420

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.504

Antimycin12.5-50 ug/mL Antimycin A?

-1.129

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.103

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.627

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.269

PA8240.2-2 ug/mL PA-824?

-0.109

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.478

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.051

Verapamil50 uM Verapamil?

-1.492

mercaptoethanol2 mM 2-Mercaptoethanol?

0.056

methoxatin10-20 ug/mL Methoxatin?